Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
boston blog main
boston top stories
fda
4
×
life sciences
national blog main
4
×
biotech
clinical trials
national top stories
new york blog main
new york top stories
drugs
ipo
renaissance capital
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
480 biomedical
akcea therapeutics
aligos therapeutics
alnylam pharmaceuticals
antibiotics
arsenal medical
arvinas
astrazeneca
baker brothers life sciences
benzodiazepine
biotech ipos
blackstone group
blepharitis
bob langer
boulder/denver
boulder/denver blog main
boulder/denver top stories
carbapenem-resistant enterobacteriaceae
cavion
celgene
cephalgia
chronic hepatitis b virus
What
way
4
×
biotechs
company
ipo
ipos
make
alnylam
approves
biotech
cells
central
chose
close
cns
debut
developing
device
disorder
drug
drugs
ema
emerged
employ
europe
fda
firms
follows
gene
harmful
hits
interference
kept
late
leads
life
lyra
markets
medical
medicine
medicines
Language
unset
Current search:
way
×
fda
×
" national blog main "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug